SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)

Condition:   AsthmaIntervention:   Drug: MK0476, montelukast sodium / Duration of Treatment: 8 WeeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials